GB1378134A - Process for the purification of carcinoembryonic antigen - Google Patents
Process for the purification of carcinoembryonic antigenInfo
- Publication number
- GB1378134A GB1378134A GB2261173A GB2261173A GB1378134A GB 1378134 A GB1378134 A GB 1378134A GB 2261173 A GB2261173 A GB 2261173A GB 2261173 A GB2261173 A GB 2261173A GB 1378134 A GB1378134 A GB 1378134A
- Authority
- GB
- United Kingdom
- Prior art keywords
- particle size
- microgranular
- meg
- cellulose
- capacity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000012406 Carcinoembryonic Antigen Human genes 0.000 title abstract 2
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 title abstract 2
- 238000000746 purification Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 239000002245 particle Substances 0.000 abstract 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- JVIPLYCGEZUBIO-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dioxoisoindole-5-carboxylic acid Chemical compound O=C1C2=CC(C(=O)O)=CC=C2C(=O)N1C1=CC=C(F)C=C1 JVIPLYCGEZUBIO-UHFFFAOYSA-N 0.000 abstract 1
- 229920000936 Agarose Polymers 0.000 abstract 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 abstract 1
- 239000005695 Ammonium acetate Substances 0.000 abstract 1
- 101000653791 Bos taurus Protein S100-A12 Proteins 0.000 abstract 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 abstract 1
- 229920002307 Dextran Polymers 0.000 abstract 1
- 229920001425 Diethylaminoethyl cellulose Polymers 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000011543 agarose gel Substances 0.000 abstract 1
- 229940043376 ammonium acetate Drugs 0.000 abstract 1
- 235000019257 ammonium acetate Nutrition 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000001768 carboxy methyl cellulose Substances 0.000 abstract 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 abstract 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 238000005342 ion exchange Methods 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J47/00—Ion-exchange processes in general; Apparatus therefor
- B01J47/02—Column or bed processes
- B01J47/04—Mixed-bed processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/26—Cation exchangers for chromatographic processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J47/00—Ion-exchange processes in general; Apparatus therefor
- B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US252700A US3867363A (en) | 1970-06-01 | 1972-05-12 | Carcinoembryonic antigens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1378134A true GB1378134A (en) | 1974-12-18 |
Family
ID=22957148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2261173A Expired GB1378134A (en) | 1972-05-12 | 1973-05-11 | Process for the purification of carcinoembryonic antigen |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS5912990B2 (de) |
| AU (1) | AU468779B2 (de) |
| BE (1) | BE799405A (de) |
| CA (1) | CA948991A (de) |
| CH (1) | CH583036A5 (de) |
| DD (1) | DD107293A5 (de) |
| DE (1) | DE2323955A1 (de) |
| DK (1) | DK133559B (de) |
| FR (1) | FR2184753B1 (de) |
| GB (1) | GB1378134A (de) |
| IL (1) | IL42119A (de) |
| IT (1) | IT998101B (de) |
| NL (1) | NL7306346A (de) |
| SE (1) | SE403912B (de) |
| ZA (1) | ZA732770B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4146603A (en) * | 1977-02-18 | 1979-03-27 | Research Corporation | Tumor specific glycoproteins and method for detecting tumorigenic cancers |
| CA1225930A (en) * | 1982-06-07 | 1987-08-25 | Otto A. Gansow | Metal chelate conjugated monoclonal antibodies |
| JPS6076395A (ja) * | 1983-10-03 | 1985-04-30 | Dainippon Screen Mfg Co Ltd | 印刷版の溶出装置 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3697638A (en) * | 1970-06-01 | 1972-10-10 | Hoffmann La Roche | Antigens |
-
1973
- 1973-04-11 CH CH519673A patent/CH583036A5/xx not_active IP Right Cessation
- 1973-04-20 IT IT23343/73A patent/IT998101B/it active
- 1973-04-24 ZA ZA732770A patent/ZA732770B/xx unknown
- 1973-04-25 CA CA169,501A patent/CA948991A/en not_active Expired
- 1973-04-27 IL IL42119A patent/IL42119A/en unknown
- 1973-04-30 AU AU54989/73A patent/AU468779B2/en not_active Expired
- 1973-05-07 NL NL7306346A patent/NL7306346A/xx unknown
- 1973-05-07 DK DK249773AA patent/DK133559B/da not_active IP Right Cessation
- 1973-05-10 JP JP48051263A patent/JPS5912990B2/ja not_active Expired
- 1973-05-10 DD DD170753A patent/DD107293A5/xx unknown
- 1973-05-11 GB GB2261173A patent/GB1378134A/en not_active Expired
- 1973-05-11 SE SE7306698-7A patent/SE403912B/xx unknown
- 1973-05-11 FR FR7317188A patent/FR2184753B1/fr not_active Expired
- 1973-05-11 BE BE131003A patent/BE799405A/xx not_active IP Right Cessation
- 1973-05-11 DE DE2323955A patent/DE2323955A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DD107293A5 (de) | 1974-07-20 |
| CA948991A (en) | 1974-06-11 |
| IL42119A (en) | 1976-08-31 |
| DE2323955A1 (de) | 1973-11-22 |
| AU468779B2 (en) | 1976-01-22 |
| NL7306346A (de) | 1973-11-14 |
| SE403912B (sv) | 1978-09-11 |
| CH583036A5 (de) | 1976-12-31 |
| BE799405A (fr) | 1973-11-12 |
| IT998101B (it) | 1976-01-20 |
| FR2184753B1 (de) | 1977-11-04 |
| JPS4947521A (de) | 1974-05-08 |
| JPS5912990B2 (ja) | 1984-03-27 |
| IL42119A0 (en) | 1973-06-29 |
| ZA732770B (en) | 1974-04-24 |
| AU5498973A (en) | 1974-10-31 |
| DK133559C (de) | 1977-02-21 |
| DK133559B (da) | 1976-06-08 |
| FR2184753A1 (de) | 1973-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1356911A (en) | Purification and fractionation of carcinoembryonic antigen | |
| US4343736A (en) | Process for recovering interferon | |
| Flodin et al. | Separation of acidic oligosaccharides by gel filtration | |
| TW283710B (de) | ||
| GB1321997A (en) | Carcinoembryonic antigen | |
| US4440675A (en) | Human immune interferon | |
| GB1378134A (en) | Process for the purification of carcinoembryonic antigen | |
| Cifonelli et al. | The purification of hyaluronic acid by the use of charcoal | |
| Smith et al. | Production of mitogenic factor by concanavalin A stimulated lymphocytes | |
| US3810819A (en) | Anti-tumor substance from hemolytic streptococci and process for producing the same using ammonium sulfate | |
| US3140984A (en) | Production of high activity fibrinolytic agents | |
| Sølling et al. | A rapid method for the purification of glycogen synthetase I and D utilising Concanavalin A bound to agarose | |
| US4658017A (en) | Method for the large scale purification of human fibroblast interferon | |
| Petrovic et al. | A new general method for separation of nucleic acids | |
| US3057851A (en) | Process for preparing vitamin b12 | |
| US3651231A (en) | Process for preparing lactogenic factor | |
| Phillips et al. | Gel-filtration of the α-Toxin of Clostridium oedematiens Type B | |
| Jones et al. | Nucleotides, amino acids and peptides in perchloric acid extracts of Chlamydomonas moewusii | |
| GB1295376A (de) | ||
| Dean et al. | Separation of a proteoglycan fraction from Kurloff cells stimulating protein synthesis in macrophages | |
| GB1494230A (en) | Process for the purification of alkali metal or ammonium insulin | |
| NAKAGAWA et al. | Whole cartilage keratosulfate. I. Its fractionation and characterization | |
| GB1425918A (en) | Process for enzyme purification | |
| ROCHER et al. | Care was taken to prevent exposure of all the solutions containing perphena-zine to light. After coupling, the mixture was vacuum filtered and successively washed with 500 ml dioxane, 750 ml acetone, 500 ml ethanol, 3 1 deionized water and 1 1 of 10 mM Tris-HCl (pH 7.0) containing 0.02% sodium azide, and was kept in this buffer at 4 C until used. | |
| JPS5718621A (en) | Treatment of hemolytic streptococcus having antitumor activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |